PWM
MIRM icon

Palumbo Wealth Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Palumbo Wealth Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$461K Sell
4,986
-96
-2% -$9.03K 0.11% 131
2025
Q4 		$401K Buy
5,082
+840
+20% +$60.3K 0.1% 144
2025
Q3 		$311K Sell
4,242
-1,362
-24% -$86.6K 0.1% 130
2025
Q2 		$285K Buy
5,604
+228
+4% +$10.2K 0.09% 147
2025
Q1 		$242K Buy
+5,376
New +$253K 0.08% 153

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Palumbo Wealth Management's MIRM Position: Q1 2026 in Review

Palumbo Wealth Management reduced its Mirum Pharmaceuticals (MIRM) stake by 1.9% in Q1 2026, selling an estimated $9.03K and leaving 4,986 shares worth $461K. The position accounts for 0.11% of the portfolio, ranked #131.

Palumbo Wealth Management first reported a position in MIRM in Q1 2025 and has held it in 5 quarters since. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • Palumbo Wealth Management held 4,986 shares of Mirum Pharmaceuticals worth $461K as of Q1 2026.
  • Palumbo Wealth Management sold 96 Mirum Pharmaceuticals shares in Q1 2026, an estimated $9.03K.
  • Mirum Pharmaceuticals made up 0.11% of Palumbo Wealth Management's portfolio in Q1 2026, its #131 holding.
  • Palumbo Wealth Management first reported a position in Mirum Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on Palumbo Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.